[Federal Register Volume 74, Number 249 (Wednesday, December 30, 2009)]
[Notices]
[Page 69119]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-30923]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI Discovery and Development P01.
    Date: February 2-3, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Sergei Radaev, PhD., Scientific Review Officer, 
Resources And Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Blvd., Room 
8113, Rockville, MD 20852, 301-435-5655, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Epidemiology, Prevention, Control & Population Sciences.
    Date: February 9-11, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, 5701 Marinelli Road, 
North Bethesda, MD 20852.
    Contact Person: Wlodek Lopaczynski, M.D., PhD, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Blvd., Room 
8131, Bethesda, MD 20892, 301-594-1402, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Molecular Oncology--Basic, Translational, and Clinical 
Studies.
    Date: February 9-11, 2010.
    Time: 5 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD.
    Contact Person: David G. Ransom, PhD, Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 6116 Executive Blvd., Rm. 8133, 
Bethesda, MD 20892-8328, 301-451-4757, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, SPORE in Gynecologic, Breast, and Skin Cancers.
    Date: February 17-19, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, Bethesda, MD.
    Contact Person: Caron A. Lyman, PhD, Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, 6116 Executive Blvd, Room 8119, Bethesda, 
MD 20892-8328, 301-451-4761, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, SPORE in Brain, Leukemia, Myeloma, Sarcoma, Esophageal, GI, 
HN, and Pancreatic Cancers.
    Date: February 17-19, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Shamala K. Srinivas, PhD., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 8123, Bethesda, MD 20892, 301-594-1224, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: December 21, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-30923 Filed 12-29-09; 8:45 am]
BILLING CODE 4140-01-P